Groove Biopharma

About:

Groove Biopharma develops novel microRNA therapeutics for maladies including cancer, fibrosis and infectious diseases.

Website: http://www.groovebiopharma.com

Top Investors: Alexandria Real Estate Equities, Versant Ventures, ARCH Venture Partners, Washington Research Foundation, OVP Venture Partners

Description:

Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) are involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma’s core technology addresses a new avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA. Using exclusive technology, Groove Biopharma is generating a series of lead candidates with the potential to be best-in-class therapeutics. By incorporating proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presents promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.